𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

✍ Scribed by Pullarkat, S T; Stoehlmacher, J; Ghaderi, V; Xiong, Y-P; Ingles, S A; Sherrod, A; Warren, R; Tsao-Wei, D; Groshen, S; Lenz, H-J


Book ID
111937174
Publisher
Nature Publishing Group
Year
2001
Tongue
English
Weight
116 KB
Volume
1
Category
Article
ISSN
1470-269X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Single nucleotide polymorphism in the 5β€²
✍ Eugenio Marcuello; Albert AltΓ©s; Elisabeth del Rio; Angeles CΓ©sar; Anna Menoyo; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

## Abstract Thymidylate synthase (TS) is the primary target of 5‐fluorouracil (5‐FU). A VNTR polymorphism in the TS promoter region is associated with the efficacy of 5‐FU‐based chemotherapy in colorectal cancer. A common G>C SNP at the 12th nucleotide of the second repeat in the TS\*3 alleles has

Topoisomerase-I, thymidylate synthase pr
✍ Angelo Paradiso; JanMing Xu; Anita Mangia; Annalisa Chiriatti; Gianni Simone; Al πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 229 KB

## Abstract While several studies have reported that thymidylate synthase (TS) tumour expression can be a reliable predictive marker of clinical response to 5‐Fluorouracil (5‐FU) for advanced colorectal cancer patients, only a few studies that searched for predictive factors of irinotecan (CPT‐11)